Drug treatments for covid-19: living systematic review and network meta-analysis
Impact · McMaster University · +23 more institutions
Indexed incrossrefpubmed
Abstract
Objective
To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design
Living systematic review and network meta-analysis. DATA SOURCES: WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, up to 3 December 2021 and six additional Chinese databases up to 20 February 2021. Studies identified as of 1 December 2021 were included in the analysis. STUDY SELECTION: Randomised clinical trials in which people with suspected, probable, or confirmed covid-19 were randomised to drug treatment or to standard care or placebo. Pairs of reviewers independently screened potentially eligible articles.
Citation impact
911
total citations
- FWCI
- 20.33
- Percentile
- 100%
- References
- 222
Citations per year
Authors
52Topics & keywords
Topics
Keywords
- Coronavirus disease 2019 (COVID-19)
- Meta-analysis
- 2019-20 coronavirus outbreak
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- MEDLINE
- Data science
- Medicine
- Drug
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.